BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹13 Cr | ₹15 Cr | ₹31 Cr | ₹19 Cr | ₹19 Cr |
What is the latest Net Current Assets ratio of BAL PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹13 Cr |
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹19 Cr |
How is Net Current Assets of BAL PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹13 Cr | -15.39 | |
| Mar2025 | ₹15 Cr | -50.58 | |
| Mar2024 | ₹31 Cr | 65.25 | |
| Mar2023 | ₹19 Cr | -0.55 | |
| Mar2022 | ₹19 Cr | - | |
Compare Net Current Assets of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹139.8 Cr | 2.6% | -11.8% | 10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 2.6% |
-11.8% |
10% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses